MedPath

Type I Diabetes and Non-surgical Periodontal Treatment

Not Applicable
Active, not recruiting
Conditions
Periodontitis
Periodontal Diseases
Diabetes
Type 1 Diabetes
Diabetes Mellitus
Diabetes Mellitus, Type 1
Interventions
Procedure: Non-surgical periodontal therapy
Registration Number
NCT05569525
Lead Sponsor
University of Florence
Brief Summary

Current evidence suggests a bidirectional association between periodontitis and diabetes. Periodontal therapy improves short term HbA1c levels and is safe to perform. Most studies are focused on type 2 Diabetes. Literature about the correlation between periodontitis and type 1 diabetes is scarce, since no randomized clinical trials have been performed.

The objective of the present clinical investigation is to evaluate the effects of nonsurgical treatment of periodontal disease on glycemic variability in patients with type 1 diabetes (T1DM). The hypothesis is that nonsurgical periodontal therapy affects glycemic variability in terms of time spent in hyperglycemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Diagnosis of Type 1 diabetes
  • Patients under treatment in the department of Diabetology of AOU Careggi having a microinfusor for continuous subcutaneous insulin infusion (CSII) and a Flash Glucose Monitoring (FGM) device
  • Diagnosis of periodontitis (all stages and grades)
Read More
Exclusion Criteria
  • Contraindications for non-surgical periodontal therapy
  • Pregnancy
  • History of other systemic disease (cancer, HIV, bone metabolic dysease, Head and Neck Radiotherapy, Immunosuppressive/modulating therapy)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlNon-surgical periodontal therapyPatients receiving non-surgical periodontal treatment 6 months after the enrollment.
TestNon-surgical periodontal therapyPatients receiving non-surgical periodontal treatment within 1 week from enrollment.
Primary Outcome Measures
NameTimeMethod
Glycated hemoglobin (HbA1c)6 months after the non-surgical periodontal treatment

Glycated hemoglobin (HbA1c) to evaluate glycemic variability measured as a percentage (%).

Secondary Outcome Measures
NameTimeMethod
Standard Deviation (SD) of glycaemia6 months after the non-surgical periodontal treatment

Standard Deviation: the spread of glucose readings around the average (mg/dl)

Glucose coefficient of variability (CV)6 months after the non-surgical periodontal treatment

CV is a calculation: dividing the SD by the mean glucose and multiplying by 100 to get a percentage (%).

Trial Locations

Locations (1)

Università degli Studi di Firenze

🇮🇹

Firenze, FI, Italy

© Copyright 2025. All Rights Reserved by MedPath